← Back to Search

Contact Lenses

kalifilcon A Daily Disposable Toric for Astigmatism

N/A
Waitlist Available
Research Sponsored by Bausch & Lomb Incorporated
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up one week
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing different types of soft contact lenses. It involves people who already wear these lenses. Participants will try out various lenses and report on their comfort and vision clarity.

Eligible Conditions
  • Astigmatism
  • Near-sightedness

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~one week
This trial's timeline: 3 weeks for screening, Varies for treatment, and one week for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Visual Acuity

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: kalifilcon A Daily Disposable ToricExperimental Treatment1 Intervention
kalifilcon A Daily Disposable Toric
Group II: Ultra for Astigmatism Contact LensesActive Control1 Intervention
Ultra for Astigmatism Contact Lenses
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
kalifilcon A Daily Disposable Toric
2022
N/A
~30

Find a Location

Who is running the clinical trial?

Bausch & Lomb IncorporatedLead Sponsor
257 Previous Clinical Trials
58,202 Total Patients Enrolled
19 Trials studying Astigmatism
2,429 Patients Enrolled for Astigmatism
Robert SteffenStudy DirectorBausch & Lomb Incorporated
2 Previous Clinical Trials
835 Total Patients Enrolled
~7 spots leftby Nov 2025